主要股东
注:以下部分股东代表特定权益共同体,直接或间接持有上市公司股份
| 序号 | 股东名称 | 是否机构 | 持股数(股) | 持股比例 | 持股变动数(股) | 持股数变动比例 | 投票权比例 |
|---|---|---|---|---|---|---|---|
| 1 | 礼来公司 | 是 | 395.71万 | 15.50% | 新增 | 新增 | -- |
| 2 | CTI Life Sciences Fund, L.P. | 是 | 302.79万 | 11.90% | 新增 | 新增 | -- |
| 3 | BDC Capital Inc. | 是 | 192.31万 | 7.60% | 新增 | 新增 | -- |
| 4 | Fonds de solidarite des travailleurs du Quebec (F.T.Q.) | 是 | 155.18万 | 6.10% | 新增 | 新增 | -- |
| 5 | Celgene Alpine Investment Co., LLC | 是 | 153.95万 | 6.00% | 新增 | 新增 | -- |
内部人交易
| 日期 | 股东名称 | 变动股数(万股) | 交易后持股数量(万股) | 交易价格 | 是否直接持有 | 内部人类型 |
|---|---|---|---|---|---|---|
| 2026-01-12 | Galbraith Kenneth |
|
25.73 | 0.00 | 是 | Chair & CEO |
| 2026-01-12 | Galbraith Kenneth |
|
22.68 | 22.67 | 是 | Chair & CEO |
| 2026-01-12 | Moore Paul Andrew |
|
5.81 | 0.00 | 是 | Chief Scientific Officer |
| 2026-01-12 | Moore Paul Andrew |
|
4.85 | 22.67 | 是 | Chief Scientific Officer |
| 2026-01-12 | Smith Jeffrey T L |
|
3.60 | 0.00 | 是 | EVP & Chief Medical Officer |
| 2026-01-12 | Smith Jeffrey T L |
|
2.67 | 22.67 | 是 | EVP & Chief Medical Officer |
| 2026-01-12 | Hollywood Mark |
|
13.90 | 0.00 | 是 | EVP & Chief Operating Officer |
| 2026-01-12 | Hollywood Mark |
|
13.29 | 22.67 | 是 | EVP & Chief Operating Officer |
| 2026-01-06 | PATTERSON LEONE D |
|
0.05 | 10.55 | 是 | EVP, Chief Bus & Fin Officer |
| 2026-01-05 | Moore Paul Andrew |
|
4.05 | 0.00 | 是 | Chief Scientific Officer |
| 2026-01-05 | Moore Paul Andrew |
|
3.12 | 25.10 | 是 | Chief Scientific Officer |
| 2026-01-05 | Moore Paul Andrew |
|
5.12 | 0.00 | 是 | Chief Scientific Officer |
| 2026-01-05 | Moore Paul Andrew |
|
4.04 | 25.10 | 是 | Chief Scientific Officer |
| 2026-01-05 | Galbraith Kenneth |
|
18.09 | 0.00 | 是 | Chair & CEO |
| 2026-01-05 | Galbraith Kenneth |
|
15.83 | 25.10 | 是 | Chair & CEO |
| 2026-01-05 | Galbraith Kenneth |
|
22.50 | 0.00 | 是 | Chair & CEO |
| 2026-01-05 | Galbraith Kenneth |
|
19.33 | 25.10 | 是 | Chair & CEO |
| 2026-01-05 | Smith Jeffrey T L |
|
2.89 | 0.00 | 是 | EVP & Chief Medical Officer |
| 2026-01-05 | Smith Jeffrey T L |
|
1.84 | 25.10 | 是 | EVP & Chief Medical Officer |
| 2025-12-22 | Galbraith Kenneth |
|
18.08 | 0.00 | 是 | Chair & CEO |
| 2025-12-22 | Galbraith Kenneth |
|
13.33 | 27.02 | 是 | Chair & CEO |
| 2025-01-06 | Smith Jeffrey T L |
|
2.00 | 0.00 | 是 | EVP & Chief Medical Officer |
| 2025-01-06 | Smith Jeffrey T L |
|
0.89 | 14.92 | 是 | EVP & Chief Medical Officer |
| 2025-01-06 | Galbraith Kenneth |
|
7.14 | 0.00 | 是 | Chair & CEO |
| 2025-01-06 | Galbraith Kenneth |
|
4.75 | 14.92 | 是 | Chair & CEO |
| 2025-01-06 | Galbraith Kenneth |
|
11.42 | 0.00 | 是 | Chair & CEO |
| 2025-01-06 | Galbraith Kenneth |
|
8.08 | 14.92 | 是 | Chair & CEO |
| 2025-01-06 | Moore Paul Andrew |
|
2.45 | 0.00 | 是 | Chief Scientific Officer |
| 2025-01-06 | Moore Paul Andrew |
|
1.47 | 14.92 | 是 | Chief Scientific Officer |
| 2025-01-06 | Moore Paul Andrew |
|
3.47 | 0.00 | 是 | Chief Scientific Officer |
| 2025-01-06 | Moore Paul Andrew |
|
2.33 | 14.92 | 是 | Chief Scientific Officer |